2011 - CTS-IXA


This page contains exclusive content for the member of the following sections: TTS, CTS, IXA. Log in to view.

Parallel Session 15- Coagulation and Thrombosis I (Xeno Track)

32.400 - Comparison of thrombin generation in transplanted primates recipients of pig hDaf or hDaf-GalT-KO kidney

Presenter: Claudia Maria, Radu, Padua, Italy
Authors: Claudia Maria Radu1, Sabrina Gavasso1, Massimo Boldrin3, Cristiana Bulato1, Luca Spiezia1, Andrea Perota4, Cesare Galli4, Emanuele Cozzi2,3, Paolo Simioni1

400

Comparison of thrombin generation in transplanted primates recipients of pig hDaf or hDaf-GalT-KO kidney

Claudia Maria Radu1, Sabrina Gavasso1, Massimo Boldrin3, Cristiana Bulato1, Luca Spiezia1, Andrea Perota4, Cesare Galli4, Emanuele Cozzi2,3, Paolo Simioni1

1Cardiologic, Thoracic and Vascular Sciences, University of Padua, Padua; 2Surgical and Gastrointestinal Sciences, University of Padua, Padua; 3Consortium for Research in Organ Transplantation (CORIT), Padua; 4Istituto Sperimentale Italiano L. Spallanzani, AVANTEA srl, Cremona; Italy

Introduction: Transgenic pigs expressing human complement regulator proteins (hDAF) or lacking expression of α1,3-galactosyltransferase gene (GalT-KO), have been considerated a strategy in preventing hyperacute rejection in xenotransplantation. Vascular injury and microvascular thrombosis are key features of the rejection process. Thrombin plays a central role in haemostasis through both procoagulant and anticoagulant functions. The measure in vitro of thrombin generation has been proposed as a potential relevant marker of in vivo haemostasis.

Aim of the study: To evaluate Thrombin Generation (TG) parameters in kidney transplanted primates who received kidney from hDaf or hDaf-Galt-KO transgenic pigs.

Methods: We studied TG profiles in the two groups of transplanted monkeys before transplantation and at euthanasia. TG assay was performed in poor platelet plasma by Calibrated Automated Thrombogram (Thrombinoscope). TG was triggered using 5pM Tissue Factor and 4µM phospholipids. The parameters detected was Endogenous Thrombin Potential, nM*min (ETP), maximum thrombin Concentration, nM (Cmax) and Lag Time, min (time to clot).

Results: We evaluated TG (mean ±SD) in 10 hDAF and in 8 hDAF-GalT-KO transplanted monkeys (hDAF-M and hDAF-GalT-KO-M). Before transplantation the ETP measured in the two groups was 1971.79±276.79 and 2092.50±693.90 nmol*min (p=ns), respectively; Cmax was 560.12±48 and 474±40 nM (p=ns) and Lag Time was 1.35±0.19 and 2.15±0.33 min (p=0.01), respectively. At euthanasia ETP was 892±260 and 296.48±90.14 nmol*min (p=0.008); Cmax was 240±43.14 nM and 43.50±23.48 (p=0.007) and Lag Time was 2.64±1.6 and 2.15±0.33 min (p=ns), respectively.

Conclusions: Before transplantation there is not significant different in TG in the two groups of transplanted monkeys. At euthanasia, in hDaf-GalT-KO-M we showed a significant decreased in thrombin formation, maybe due to a major consumption of the coagulation factors in comparison to hDAF-M. Data obtained could explain the consumptive coagulopathy observed in these animals, following a massive activation of clotting cascade.

 

ETP (nmol*min)

Lag Time (min)

Cmax (nM)

Before transplantation

hDaf

1971.79±276,79

1,35±0,19

560,12±48

hDAF-GalT-KO

2092,50±693,90

2,15±0,33

474±40

t test

hDAF

vs

hDAF-GalT-KO

0,94

0,01

0,17

At euthanasia

hDaf

892±260

2,64±1,6

240±43,14

hDAF-GalT-KO

296,48±101,79

2,15±0,33

43,50±23,48

t test

hDAF

vs

hDAF-GalT-KO

0,008

0,62

0,007

         

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada